{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:53:10Z","timestamp":1760608390664},"reference-count":45,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.vaccine.2006.12.015","type":"journal-article","created":{"date-parts":[[2006,12,29]],"date-time":"2006-12-29T12:11:20Z","timestamp":1167394280000},"page":"2758-2765","source":"Crossref","is-referenced-by-count":37,"title":["17D yellow fever vaccines: New insights"],"prefix":"10.1016","volume":"25","author":[{"given":"Alan D.T.","family":"Barrett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas P.","family":"Monath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronique","family":"Barban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Niedrig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk E.","family":"Teuwen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2006.12.015_bib1","series-title":"Vaccines","first-page":"1095","article-title":"Yellow fever vaccine","author":"Monath","year":"2004"},{"issue":"40","key":"10.1016\/j.vaccine.2006.12.015_bib2","first-page":"349","article-title":"Yellow fever vaccine. WHO position paper","volume":"78","author":"World Health Organization","year":"2003","journal-title":"Wkly Epidemiol Rec"},{"issue":"1","key":"10.1016\/j.vaccine.2006.12.015_bib3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11908-004-0022-5","article-title":"Yellow fever immunizations: indications and risks","volume":"6","author":"Wilson","year":"2004","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.vaccine.2006.12.015_bib4","unstructured":"World Health Organization. WHO vaccine-preventable diseases: monitoring system. 2005 global summary. Geneva: WHO; 2005."},{"key":"10.1016\/j.vaccine.2006.12.015_bib5","first-page":"50","article-title":"Progress in the control of yellow fever in Africa","volume":"80","year":"2005","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2006.12.015_bib6","series-title":"Yellow fever. Traveller's health: yellow book","author":"Arguin","year":"2005"},{"issue":"2","key":"10.1016\/j.vaccine.2006.12.015_bib7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0166-0934(03)00128-9","article-title":"MAC-ELISA and ELISA inhibition methods for detection of antibodies after yellow fever vaccination","volume":"110","author":"Vazquez","year":"2003","journal-title":"J Virol Methods"},{"issue":"8586","key":"10.1016\/j.vaccine.2006.12.015_bib8","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0140-6736(88)91425-0","article-title":"Epidemic yellow fever in eastern Nigeria, 1986","volume":"1","author":"De Cock","year":"1988","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2006.12.015_bib9","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0035-9203(89)90518-X","article-title":"Urban yellow fever epidemic in western Nigeria, 1987","volume":"83","author":"Nasidi","year":"1989","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"10","key":"10.1016\/j.vaccine.2006.12.015_bib10","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1086\/340104","article-title":"Prevention of yellow fever in persons traveling to the tropics","volume":"34","author":"Monath","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2006.12.015_bib11","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/0035-9203(74)90248-X","article-title":"Arbovirus studies in Nupeko forest, a possible natural focus of yellow fever virus in Nigeria. I. Description of the area and serological survey of humans and other vertebrate hosts","volume":"68","author":"Monath","year":"1974","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2006.12.015_bib12","series-title":"Factors in the emergence of arbovirus diseases","first-page":"143","article-title":"Epidemiology of yellow fever: current status and speculations on future trends","author":"Monath","year":"1997"},{"issue":"5","key":"10.1016\/j.vaccine.2006.12.015_bib13","doi-asserted-by":"crossref","first-page":"912","DOI":"10.4269\/ajtmh.1980.29.912","article-title":"Yellow fever in the Gambia, 1978\u20131979: epidemiologic aspects with observations on the occurrence of orungo virus infections","volume":"29","author":"Monath","year":"1980","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2006.12.015_bib14","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1001\/jama.276.14.1157","article-title":"Yellow fever: a decade of re-emergence","volume":"276","author":"Robertson","year":"1996","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.vaccine.2006.12.015_bib15","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1016\/j.vaccine.2006.06.082","article-title":"High stability of yellow fever 17D-204 vaccine: a 12-year restrospective analysis of large-scale production","volume":"25","author":"Barban","year":"2007","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2006.12.015_bib16","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1093\/nar\/17.10.3989","article-title":"Nucleotide sequence comparison of the genome of two 17D-204 yellow fever vaccines","volume":"17","author":"Dupuy","year":"1989","journal-title":"Nucleic Acids Res"},{"issue":"4715","key":"10.1016\/j.vaccine.2006.12.015_bib17","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1126\/science.4023707","article-title":"Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution","volume":"229","author":"Rice","year":"1985","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.vaccine.2006.12.015_bib18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4269\/ajtmh.2005.72.189","article-title":"Randomized, double-blind, phase III, pivotal field trial of the comparative immunogenicity, safety, and tolerability of two yellow fever 17D vaccines (Arilvax and YF-VAX) in healthy infants and children in Peru","volume":"72","author":"Belmusto-Worn","year":"2005","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.vaccine.2006.12.015_bib19","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1590\/S0034-89102005000300012","article-title":"Reactogenicity of yellow fever vaccines in a randomized, placebo-controlled trial","volume":"39","author":"Camacho","year":"2005","journal-title":"Rev Saude Publica"},{"issue":"5","key":"10.1016\/j.vaccine.2006.12.015_bib20","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1590\/S0034-89102004000500009","article-title":"Immunogenicity of WHO-17D and Brazilian 17DD yellow fever vaccines: a randomized trial","volume":"38","author":"Camacho","year":"2004","journal-title":"Rev Saude Publica"},{"issue":"5","key":"10.1016\/j.vaccine.2006.12.015_bib21","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4269\/ajtmh.2002.66.533","article-title":"Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial","volume":"66","author":"Monath","year":"2002","journal-title":"Am J Trop Med Hyg"},{"issue":"12","key":"10.1016\/j.vaccine.2006.12.015_bib22","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1046\/j.1365-3156.1999.00496.x","article-title":"Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA","volume":"4","author":"Niedrig","year":"1999","journal-title":"Trop Med Int Health"},{"issue":"2","key":"10.1016\/j.vaccine.2006.12.015_bib23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1096-9071(199810)56:2<159::AID-JMV10>3.0.CO;2-B","article-title":"Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection","volume":"56","author":"Reinhardt","year":"1998","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2006.12.015_bib24","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0168-1702(98)00036-7","article-title":"Yellow fever 17D vaccine virus isolated from healthy vaccinees accumulates very few mutations","volume":"55","author":"Xie","year":"1998","journal-title":"Virus Res"},{"issue":"30","key":"10.1016\/j.vaccine.2006.12.015_bib25","first-page":"643","article-title":"Fever, jaundice, and multiple organ system failure associated with 17D-derived yellow fever vaccination 1996\u20132001","volume":"50","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9276","key":"10.1016\/j.vaccine.2006.12.015_bib26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(01)05341-7","article-title":"Hepatitis and death following vaccination with 17D-204 yellow fever vaccine","volume":"358","author":"Chan","year":"2001","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2006.12.015_bib27","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jcv.2006.02.005","article-title":"Yellow fever vaccine-associated viscerotropic disease and death in Spain","volume":"36","author":"Doblas","year":"2006","journal-title":"J Clin Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2006.12.015_bib28","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1017\/S0950268804002602","article-title":"Risk of fatal adverse events associated with 17DD yellow fever vaccine","volume":"132","author":"Struchiner","year":"2004","journal-title":"Epidemiol Infect"},{"issue":"9276","key":"10.1016\/j.vaccine.2006.12.015_bib29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0140-6736(01)05326-0","article-title":"Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases","volume":"358","author":"Vasconcelos","year":"2001","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.vaccine.2006.12.015_bib30","first-page":"936","article-title":"Adverse effects of attenuated yellow fever vaccine with multiple organ injury\u2014a case report","volume":"85","author":"Zhou","year":"2005","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"9276","key":"10.1016\/j.vaccine.2006.12.015_bib31","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(01)05327-2","article-title":"Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases","volume":"358","author":"Martin","year":"2001","journal-title":"Lancet"},{"issue":"RR-17","key":"10.1016\/j.vaccine.2006.12.015_bib32","first-page":"1","article-title":"Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002","volume":"51","author":"Cetron","year":"2002","journal-title":"MMWR Recomm Rep"},{"issue":"6","key":"10.1016\/j.vaccine.2006.12.015_bib33","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1001\/jama.198.6.671","article-title":"Fatal viral encephalitis following 17D yellow fever vaccine inoculation. Report of a case in a 3-year-old child","volume":"198","year":"1966","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.vaccine.2006.12.015_bib34","first-page":"131","article-title":"Fatal myeloencephalitis following yellow fever vaccination in a case with HIV infection","volume":"85","author":"Kengsakul","year":"2002","journal-title":"J Med Assoc Thai"},{"issue":"25","key":"10.1016\/j.vaccine.2006.12.015_bib35","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1016\/j.vaccine.2005.01.089","article-title":"Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events","volume":"23","author":"Khromava","year":"2005","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2006.12.015_bib36","first-page":"244","article-title":"Age-related risk of adverse events following yellow fever vaccination in Australia","volume":"28","author":"Lawrence","year":"2004","journal-title":"Commun Dis Intell"},{"issue":"9438","key":"10.1016\/j.vaccine.2006.12.015_bib37","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0140-6736(04)17017-7","article-title":"History of thymoma and yellow fever vaccination","volume":"364","author":"Barwick","year":"2004","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.vaccine.2006.12.015_bib38","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1016\/j.vaccine.2006.01.009","article-title":"Characterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil","volume":"24","author":"Engel","year":"2006","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2006.12.015_bib39","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.3201\/eid1009.040197","article-title":"Genetic divergence and dispersal of yellow fever virus, Brazil","volume":"10","author":"Vasconcelos","year":"2004","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2006.12.015_bib40","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/infdis\/169.3.512","article-title":"Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis","volume":"169","author":"Jennings","year":"1994","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2006.12.015_bib41","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1006\/viro.2001.1168","article-title":"Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil","volume":"290","author":"Galler","year":"2001","journal-title":"Virology"},{"issue":"10","key":"10.1016\/j.vaccine.2006.12.015_bib42","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1086\/320199","article-title":"Experimental yellow fever virus infection in the Golden Hamster (Mesocricetus auratus). I. Virologic, biochemical, and immunologic studies","volume":"183","author":"Tesh","year":"2001","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2006.12.015_bib43","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1086\/320200","article-title":"Experimental yellow fever virus infection in the Golden Hamster (Mesocricetus auratus) II. Pathology","volume":"183","author":"Xiao","year":"2001","journal-title":"J Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2006.12.015_bib44","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1590\/S0037-86822004000700011","article-title":"Yellow fever virus isolated from a fatal post vaccination event: an experimental comparative study with the 17DD vaccine strain in the Syrian hamster (Mesocricetus auratus)","volume":"37","author":"Rodrigues","year":"2004","journal-title":"Rev Soc Bras Med Trop"},{"issue":"30","key":"10.1016\/j.vaccine.2006.12.015_bib45","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1016\/j.vaccine.2005.03.002","article-title":"Yellow fever vaccination: how much is enough?","volume":"23","author":"Massad","year":"2005","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0601334X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0601334X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T11:23:26Z","timestamp":1556018606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X0601334X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":45,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0264410X0601334X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.12.015","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}